review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Monica M. McNeal | |
Richard L. Ward | |||
P407 | language of work or name | English | Q1860 |
P921 | main subject | vaccine | Q134808 |
P304 | page(s) | S101-7 | |
P577 | publication date | 2010-09-01 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | VP6: A candidate rotavirus vaccine | |
VP6: A Candidate Rotavirus Vaccine | |||
P478 | volume | 202 Suppl |
Q41326217 | Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate |
Q36210208 | Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates. |
Q40218330 | Enhancement of VP6 immunogenicity and protective efficacy against rotavirus by VP2 in a genetic immunization. |
Q52648250 | Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine. |
Q37473348 | Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model |
Q42233820 | Immunogenicity and protective efficacy of yeast extracts containing rotavirus-like particles: a potential veterinary vaccine. |
Q34510430 | Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice |
Q34711833 | Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea |
Q40527380 | Rhesus rotavirus VP6 regulates ERK-dependent calcium influx in cholangiocytes. |
Q38743049 | Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles |
Q58759991 | Rotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model |
Q37135255 | Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine |
Q40243520 | Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs. |
Q33812653 | Subviral particle as vaccine and vaccine platform |
Q33720570 | Synthesis and characterization of different immunogenic viral nanoconstructs from rotavirus VP6 inner capsid protein |
Q41350061 | Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice. |
Q57490842 | The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination |
Q39232838 | The rotavirus vaccine development pipeline. |
Q37691015 | Transfer of Anti-Rotavirus Antibodies during Pregnancy and in Milk Following Maternal Vaccination with a Herpes Simplex Virus Type-1 Amplicon Vector. |
Q34907018 | Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice |
Q39063072 | Understanding internalization of rotavirus VP6 nanotubes by cells: towards a recombinant vaccine |
Search more.